Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 9043945)

Published in Int Immunol on January 01, 1997

Authors

X Chen1, F Martin, K A Forbush, R M Perlmutter, J F Kearney

Author Affiliations

1: Department of Microbiology, University of Alabama at Birmingham 35294-3300, USA.

Articles citing this

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A (2002) 4.86

B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med (1999) 4.52

BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med (2000) 3.43

A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med (2006) 2.60

Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest (2001) 2.26

Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med (2002) 2.16

Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest (2004) 1.94

Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med (2008) 1.82

Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood (2010) 1.79

The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol (2002) 1.62

TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol (2005) 1.56

B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2006) 1.55

The role of Bruton's tyrosine kinase in the development and BCR/TLR-dependent activation of AM14 rheumatoid factor B cells. J Leukoc Biol (2013) 1.52

Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J Exp Med (1997) 1.46

Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol (2009) 1.39

MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Exp Med (1999) 1.33

Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. Proc Natl Acad Sci U S A (2009) 1.30

Innate-like B cells. Springer Semin Immunopathol (2005) 1.24

B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. J Exp Med (1999) 1.24

A novel mechanism for B cell repertoire maturation based on response by B cell precursors to pre-B receptor assembly. J Exp Med (1998) 1.16

A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A (2011) 1.14

Generation of B cell memory to the bacterial polysaccharide alpha-1,3 dextran. J Immunol (2009) 1.08

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res Ther (2006) 1.06

Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med (2006) 1.02

Genetic control of DH reading frame and its effect on B-cell development and antigen-specifc antibody production. Crit Rev Immunol (2010) 1.02

A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation. Autoimmunity (2010) 1.01

B cell TLRs and induction of immunoglobulin class-switch DNA recombination. Front Biosci (Landmark Ed) (2012) 0.99

Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases? Clin Exp Immunol (2005) 0.95

BLyS-mediated modulation of naive B cell subsets impacts HIV Env-induced antibody responses. J Immunol (2012) 0.93

Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes. Clin Exp Immunol (2004) 0.91

Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab Invest (2008) 0.91

Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. Am J Pathol (2003) 0.88

Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells. Immunol Cell Biol (2011) 0.88

Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes. Diabetes (2012) 0.87

Insulinoma-released exosomes activate autoreactive marginal zone-like B cells that expand endogenously in prediabetic NOD mice. Eur J Immunol (2013) 0.83

Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A (2013) 0.81

Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10. Nat Immunol (2017) 0.81

Antibodies that bind complex glycosaminoglycans accumulate in the Golgi. Proc Natl Acad Sci U S A (2013) 0.79

Regulation of B cell tolerance by 129-derived chromosome 1 loci in C57BL/6 mice. Arthritis Rheum (2008) 0.79

Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease. Eur J Immunol (2012) 0.78

C1q deficiency promotes the production of transgenic-derived IgM and IgG3 autoantibodies in anti-DNA knock-in transgenic mice. Mol Immunol (2007) 0.78

Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets. Eur J Immunol (2013) 0.77

Maintenance of tolerance by regulation of anti-myeloperoxidase B cells. J Am Soc Nephrol (2008) 0.77

Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis. J Immunol (2015) 0.76

Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies. J Exp Med (2017) 0.75

B cell depletion in autoimmune diabetes: insights from murine models. Expert Opin Ther Targets (2011) 0.75

A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens. J Clin Invest (2017) 0.75

Phenotyping of autoreactive B cells with labeled nucleosomes in 56R transgenic mice. Sci Rep (2017) 0.75

Articles by these authors

The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03

A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56

Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J Cell Biol (1986) 8.65

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41

Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines. Nature (1984) 5.75

A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell (1985) 5.21

Subclass restriction of murine anti-carbohydrate antibodies. J Immunol (1978) 4.99

Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity (2001) 4.92

Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell (1990) 4.84

Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell (1986) 4.68

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta (1991) 4.16

454 Pyrosequencing analyses of forest soils reveal an unexpectedly high fungal diversity. New Phytol (2009) 4.04

Early restriction of the human antibody repertoire. Science (1987) 3.90

INTESTINAL OBSTRUCTION DUE TO GALL-STONES: WITH REPORT OF THREE SUCCESSFUL CASES. Ann Surg (1912) 3.84

Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science (1991) 3.84

Tom40 forms the hydrophilic channel of the mitochondrial import pore for preproteins [see comment]. Nature (1998) 3.77

Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J (1990) 3.62

B lymphocyte differentiation induced by lipopolysaccharide. I. Generation of cells synthesizing four major immunoglobulin classes. J Immunol (1975) 3.62

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology (1987) 3.35

Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein. J Cell Biol (1987) 3.33

Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn). Cell (1991) 3.30

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res (1994) 3.30

Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A (1985) 3.28

Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell (1992) 3.17

Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol (2001) 3.08

Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J Exp Med (1984) 3.02

Developmentally controlled expression of immunoglobulin VH genes. Science (1985) 2.96

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem (1999) 2.86

Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck). Mol Cell Biol (1988) 2.80

Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature (1996) 2.79

Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol (1997) 2.77

Evidence that murine pre-B cells synthesise mu heavy chains but no light chains. Nature (1979) 2.74

IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol (1999) 2.73

Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun (2005) 2.69

Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity (2000) 2.58

B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol (2001) 2.57

Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol (1999) 2.57

B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev (2000) 2.55

Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (1995) 2.53

Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin. Mol Cell Biol (1987) 2.52

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med (1994) 2.52

Laparoscopic treatment vs open surgery in the solution of major incisional and abdominal wall hernias with mesh. Surg Endosc (1999) 2.46

Translational activation of the lck proto-oncogene. Nature (1988) 2.41

A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin Immunol Immunopathol (1982) 2.41

Demonstration of antigens related to colonic cancer in the human digestive system. Int J Cancer (1970) 2.35

Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol (1989) 2.34

Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice. Eur J Immunol (1981) 2.33

Erroneous diagnosis of hemorrhage from esophageal varices. Am J Dig Dis (1969) 2.30

The transcriptome of the arbuscular mycorrhizal fungus Glomus intraradices (DAOM 197198) reveals functional tradeoffs in an obligate symbiont. New Phytol (2011) 2.29

The Tim core complex defines the number of mitochondrial translocation contact sites and can hold arrested preproteins in the absence of matrix Hsp70-Tim44. EMBO J (1997) 2.28

Anti-DNA autoantibodies in (NZB X NZW)F1 mice are clonally heterogeneous, but the majority share a common idiotype. J Immunol (1982) 2.25

Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity (2000) 2.23

Organization and expression of immunoglobulin genes in fetal liver hybridomas. Proc Natl Acad Sci U S A (1981) 2.23

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

CD22 regulates thymus-independent responses and the lifespan of B cells. Nature (1997) 2.16

Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer (2009) 2.14

Inhibition of T-cell receptor beta-chain gene rearrangement by overexpression of the non-receptor protein tyrosine kinase p56lck. EMBO J (1992) 2.12

Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain (2000) 2.06

Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J (1995) 2.02

Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J Immunol (1978) 1.99

The active site of yeast aspartyl-tRNA synthetase: structural and functional aspects of the aminoacylation reaction. EMBO J (1994) 1.99

A dominant-negative transgene defines a role for p56lck in thymopoiesis. EMBO J (1993) 1.98

Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney murine leukemia virus structural genes via the metallothionein promoter. Mol Cell Biol (1987) 1.94

Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature (1983) 1.93

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell (1994) 1.93

Thymic tumorigenesis induced by overexpression of p56lck. Proc Natl Acad Sci U S A (1991) 1.93

Positive and negative selection invoke distinct signaling pathways. J Exp Med (1996) 1.86

Fyn can partially substitute for Lck in T lymphocyte development. Immunity (1996) 1.85

Developmental regulation of lck gene expression in T lymphocytes. J Exp Med (1991) 1.82

Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases. EMBO J (1987) 1.80

Impaired expansion of mouse B cell progenitors lacking Btk. Immunity (1995) 1.79

Functional dissection of the lck proximal promoter. Mol Cell Biol (1992) 1.78

Nucleotide sequence analysis of a cDNA encoding human ubiquitin reveals that ubiquitin is synthesized as a precursor. J Biol Chem (1985) 1.77

Control of B cell development by Ras-mediated activation of Raf. EMBO J (1997) 1.76

Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs (1997) 1.76

Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. Immunity (2000) 1.74

Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem (1999) 1.73

Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int Immunol (1990) 1.72

Structure of the murine lck gene and its rearrangement in a murine lymphoma cell line. Mol Cell Biol (1988) 1.66

Brief report: heavy-chain deposition disease. N Engl J Med (1993) 1.63

Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem (1995) 1.62

The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood (1995) 1.61

Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol (2001) 1.60

The generation of diversity in phosphorylcholine-binding antibodies. Adv Immunol (1984) 1.59

An activated lck transgene promotes thymocyte development in RAG-1 mutant mice. Immunity (1994) 1.55

Terminal deoxynucleotidyl transferase and repertoire development. Immunol Rev (2000) 1.55

Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med (1979) 1.54